Anecdotal reports indicate that radiologists are struggling to keep up with rising demand, but researchers sought to better quantify this crisis. 

“Any action that would increase medical liability costs carries the potential negative consequence of physicians leaving our state to practice elsewhere," the two said. 

Jonathan Gross, MD, argues that diagnostic and interventional radiology were “not developed with sustainability in mind.”

The alleged scheme involved a series of diagnostic procedures that, according to the U.S. government, were not medically necessary. 

The combined-AI system used for this research “demonstrated superior performance compared with similar studies for both functions,” researchers noted.

Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.

The publication's current editor-in-chief is Valentin Fuster, MD, PhD. Harlan M. Krumholz, MD, will begin his five-year term in 2024.

The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent. 

Credit analysts switched their forecast from “negative” to “stable,” highlighting both higher patient volumes and revenue per unit. 

UCLA's Dieter R. Enzmann, MD, detailed his thesis in a perspective piece published in Academic Radiology.